Hongyang Yu

Hongyang Yu


Research Focus & Metrics

Academic Career Length

6Years (2021-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
13 October 2021 in Physiology and Molecular Biology of Plants
Verified
Journal Article
Open access
PDF file
JCJie Cheng
Jie Cheng
SZSongsong Zhou
Songsong Zhou
KYKun Yang
Kun Yang
HYHongyang Yu
Hongyang Yu
RCRongrong Chen
Rongrong Chen
JSJianbo Song
Jianbo Song
RNA helicase catalyzes the denaturation of DNA or the unwinding of double-stranded RNA. It is vital to RNA splicing, transport, editing, degradation and the initiation of protein translation. However, the function of RNA helicase in Medicago truncatula has rarely been reported. In this study, 170 putative RNA helicase genes were identified in the M. truncatula genome, and classified into three subfamilies based on the presence of either a DEAD-box (52 genes), DEAH-box (38 genes), or DExD/H-box (80 genes) in their coding regions. Additionally, conserved helicase_C domains and other functional domains (e.g., the HA2, DUF, and ZnF domains) were also present in these genes. Chromosomal mapping and synteny analyses showed that there were tandem and segment duplications of RNA helicase genes. Furthermore, transcriptome and real-time PCR analysis showed that the expression of 35 RNA helicase genes was affected by abiotic stress. To be specific, 17, 12 and 19 genes were regulated by salt, drought and cold stress, respectively. It is worth noting that MtDEAD8, MtDEAH3, MtDExD/H18 and MtDExD/H23 responded to all three types of stress. These results provide valuable information for understanding the RNA helicase genes in M. truncatula and their abiotic stress-related functions.

2 September 2024 in Brazilian Journal of Otorhinolaryngology
Verified
Journal Article
Open access
YZYing Zhang
Ying Zhang
YCYue Cui
Yue Cui
CHCongfan Hao
Congfan Hao
YLYingjie Li
Yingjie Li
XHXinyang He
Xinyang He
HYHongyang Yu
Hongyang Yu
Objective: The aim of this study was to construct a prognostic model based on the TP53 mutation to calculate prognostic risk scores of patients with HPSCC. Methods: TP53 mutation and transcriptome data were downloaded from the TCGA databases. Gene expression data from GSE65858, GSE41613, GSE3292, GSE31056, GSE39366, and GSE227156 datasets were downloaded from the GEO database. GSEA, univariate, multivariate Cox analyses, and LASSO analysis were employed to identify key genes and construct the prognostic model. ROC curves were utilized to validate the OS and RFS results obtained from the model. The associations between risk scores with various clinicopathological characteristics and immune scores were analyzed via ggplot2, corrplot package, and GSVA, respectively. Single-cell sequencing data was analyzed via unbiased clustering and SingleR cell annotations. Results: Initially, two key genes, POLD2 and POLR2G, were identified and utilized to construct the prognostic model. Samples were divided into different risk groups via the risk scores obtained from the model, with high-risk group samples exhibiting poorer prognosis. Furthermore, the risk score exhibited a positive correlation with lymphatic metastasis in patients and the immune scores of CD4+ T, CD8+ T, dendritic cell, macrophage, and neutrophil. The immune responses also exhibited notable disparities between the high- and low-risk groups. The results of single-cell sequencing analysis demonstrated that epithelial cells and macrophages were relatively abundant in HPSCC samples. POLD2 and POLR2G exhibited higher expressions in epithelial cells, with most of the identified pathways also enriched in epithelial cells. Conclusion: The prognostic model exhibited a significant capacity for predicting the prognosis of HSPCC samples based on the TP53 mutation conditions and may also predict the cancer characteristics and immune infiltration scores of samples via different risk scores obtained from the model. Level of evidence: Level 5.

16 December 2025 in Discover Oncology
Verified
Journal Article
Open access
PDF file
WLWenhui Li
Wenhui Li
HLHao Lu
Hao Lu
HTHeyuan Tang
Heyuan Tang
CMChenze Ma
Chenze Ma
ZWZiyu Wei
Ziyu Wei
HYHongyang Yu
Hongyang Yu
Purpose This study sought to determine independent predictors of suicide among patients with lung cancer and to establish a dynamic nomogram to predict suicide risk, with the ultimate goal of enabling early recognition and prevention in high-risk populations. Methods We analyzed 188,147 lung cancer cases from the most recent Surveillance, Epidemiology, and End Results (SEER) database (2004–2015) to identify predictors of suicide risk and develop a predictive model. The cohort was randomized into a training and validation group. Validation consisted of assessing the consistency index (C-index), subject-operating characteristic curves (ROC), and calibration curves. Results A total of 188,147 eligible lung cancer patients were enrolled and randomized into the training and validation groups. Multifactorial Cox regression analysis showed that age, race, sex, grade, and marital were independent predictors of suicide in lung cancer patients. The accuracy of the nomogram was evaluated by C-index and ROC curves, which showed acceptable performance on both training and validation sets. In addition, calibration plots showed that nomograms containing all these factors showed strong predictive accuracy. Conclusion This study identified key risk factors for suicide in lung cancer patients and developed a dynamic nomogram that provided individualized risk predictions based on multifactorial clinical and pathological parameters. The model offered a superior alternative to traditional static risk scales, enabling early identification of high-risk individuals to support timely prevention and intervention. Furthermore, it has been implemented as a web-based visual tool, allowing convenient, real-time, and personalized suicide risk assessment. By facilitating early detection and intervention, this approach can help clinicians improve decision-making efficiency and provide more precise, patient-centered care, ultimately contributing to better psychological outcomes and quality of life for lung cancer patients.